Insights

Is Ellume laying the foundations to list on the ASX?

Is Ellume coming to the ASX?
The post Is Ellume laying the foundations to list on the ASX? appeared first on The Motley Fool Australia. –

There have been a number of high profile initial public offerings (IPOs) in recent weeks. These include GQG Partners Inc. (ASX: GQG), SiteMinder Ltd (ASX: SDR), and Vulcan Steel Limited (ASX: VSL).

Potentially joining these shares on the ASX boards in the near future is COVID-testing kit company, Ellume.

Is Ellume going to launch an IPO soon?

According to the AFR, Ellume has been doing the groundwork for a potential listing in the near future.

The Queensland-based biotech has tasked stockbrokers Morgans and Ord Minnett to raise $85 million in a pre-IPO funding round. Sources have suggested that this will give Ellume a valuation in the range of $600 million to $800 million.

The report states that a spokesperson has confirmed that these pre-IPO funds would be used for working capital, sales and marketing, new product development, and capital expansion.

What does Ellume do?

Ellume is a biotechnology company that develops, manufactures, and commercialises the next generation of digital diagnostic products for healthcare professionals and consumers. Its focus is the accurate diagnosis of common infectious diseases.

The company came onto investor radars earlier this year after it signed a massive US$231 million contract with the US government to supply COVID-19 testing kits. This agreement was signed after its testing kit became the first non-prescription over-the-counter self-test authorised by the U.S. Food and Drug Administration.

The big question on investors’ lips if it does IPO will be how sustainable its current revenues are. When COVID-19 testing finally slows down, investors will be wanting assurance that Ellume’s revenues won’t dry up.

What are your other options?

Time will tell whether Ellume goes ahead with an IPO in the future. But in the meantime, if you’re wanting to gain exposure to COVID-19 testing, then you can do this through a number of ASX shares.

These include Healius Ltd (ASX: HLS) and Sonic Healthcare Limited (ASX: SHL). Both companies have been growing at an explosive rate over the last 18 months thanks to heightened demand for testing.

The post Is Ellume laying the foundations to list on the ASX? appeared first on The Motley Fool Australia.

Should you invest $1,000 in Ellume right now?

Before you consider Ellume, you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Ellume wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

More reading

Macquarie warns the next ASX market downturn could come as soon as February

2 excellent blue chip ASX 200 shares to buy now

5 fantastic ASX shares to buy right now

2 blue chip ASX 200 shares analysts love

Leading brokers name 3 ASX shares to buy today

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Sonic Healthcare Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!